JPRN-UMIN000002420已完成2 期
A randomized phase II study of TS-1+Cisplatin versus Vinorelbine+Cisplatin,with thoracic radiotherapy for locally advanced non-small cell lung cancer. - A randomized phase II study of TS-1+Cisplatin versus Vinorelbine+Cisplatin,with thoracic radiotherapy for locally advanced non-small cell lung cancer.
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 110
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •-T3N1 -SVC syndrome. -Clinically significant pleural or pericardial effusion,Contralateral Hilar lymph node metastasis, -Patients with concurrent serious infections or complications -Continuous watery diarrhea -Paralysis of the intestine, or ileus -Significant interstitial pneumonitis ,pulmonary fibrosis or severe emphysema in Chest Xp -The presence of other concomitant cancers -Concomitant therapy with another new anticancer drug, phenytoin, warfarin or flucytocine -Inadequately controlled diabetes mellitus -HBs Ag is positive -A history of serious drug allergy -Mental disease or psychotic manifestation -Pregnancy,breast feeding or wish of future bearing -Other conditions not suitable for this study
研究者
相似试验
已完成
2 期
A randomized phase II study of cisplatin+TS-1 versus cisplatin+docetaxel, with thoracic radiotherapy for locally advanced non-small cell lung cancer (TORG1018)on-small cell lung cancerJPRN-UMIN000005993Thoracic Oncology Research Group110
已完成
2 期
A phase II study of cisplatin with TS-1 for patients with cancer of primary unknowJPRN-C000000271Department of Medical Oncology, Kinki University School of Medicine45
已完成
2 期
A randomized phase II study of Cisplatin plus S-1 versus Cisplatin plus Pemetrexed, with thoracic radiotherapy for locally advanced non-squamous non-small cell lung cancerJPRN-UMIN000009914ational Cancer Center Hospital East100
已完成
2 期
Phase II trial of TS-1 and cisplatin in patients with Carcinoma of Unknown Primary Sites (KMOG 0607)Carcinoma of Unknown Primary SitesJPRN-UMIN000001364Kyushu Medical Oncology Group38
已完成
2 期
A phase II study of S-1/Cisplatin/Trastuzumab for human epidermal growth factor receptor 2 (HER2)-positive advanced and/or recurrent gastric canceradvanced and/or recurrent gastric cancerJPRN-UMIN000006603HOG-GC (Hiroshima oncology group of gastric cancer)25